Considerations on the EU definition of a nanomaterial: Science to support policy making

被引:118
作者
Bleeker, Eric A. J. [1 ]
de Jong, Wim H. [1 ]
Geertsma, Robert E. [1 ]
Groenewold, Monique [1 ]
Heugens, Evelyn H. W. [1 ]
Koers-Jacquemijns, Marjorie [1 ]
van de Meent, Dik [1 ]
Popma, Jan R. [1 ]
Rietveld, Anton G. [1 ]
Wijnhoven, Susan W. P. [1 ]
Cassee, Flemming R. [1 ]
Oomen, Agnes G. [1 ]
机构
[1] Natl Inst Publ Hlth & Environm, RIVM, NL-3720 BA Bilthoven, Netherlands
关键词
Nanomaterials; Definition; Risk assessment; Regulatory frameworks; Measurement techniques; Guidance; FOOD; NANOPARTICLES;
D O I
10.1016/j.yrtph.2012.11.007
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
In recent years, an increasing number of applications and products containing or using nanomaterials have become available. This has raised concerns that some of these materials may introduce new risks for humans or the environment. A clear definition to discriminate nanomaterials from other materials is prerequisite to include provisions for nanomaterials in legislation. In October 2011 the European Commission published the 'Recommendation on the definition of a nanomaterial', primarily intended to provide unambiguous criteria to identify materials for which special regulatory provisions might apply, but also to promote consistency on the interpretation of the term 'nanomaterial'. In this paper, the current status of various regulatory frameworks of the European Union with regard to nanomaterials is described, and major issues relevant for regulation of nanomaterials are discussed. This will contribute to better understanding the implications of the choices policy makers have to make in further regulation of nanomaterials. Potential issues that need to be addressed and areas of research in which science can contribute are indicated. These issues include awareness on situations in which nano-related risks may occur for materials that fall outside the definition, guidance and further development of measurement techniques, and dealing with changes during the life cycle. (C) 2012 Elsevier Inc. All rights reserved.
引用
收藏
页码:119 / 125
页数:7
相关论文
共 53 条
[1]  
[Anonymous], PREL GUID NOT SAMPL
[2]  
[Anonymous], CONS WHETH FDA REG P
[3]  
[Anonymous], 2002, DIRECTIVE 2001 95 EC
[4]  
[Anonymous], 1998, OFFICIAL J EUROPEA L, V331, P1
[5]  
[Anonymous], 2006, Official Journal of the European Union, L, V396, P1
[6]  
[Anonymous], 2001, Official Journal of the European Communities, VL311, P67
[7]  
[Anonymous], 2003, OFFICIAL J L, V37, P24, DOI DOI 10.1016/S1578-1550(11)70052-3
[8]  
[Anonymous], 2003, Off. J. Eur. Union, VL037, P19
[9]  
[Anonymous], 2009, Off J Eur Union, V52, P59
[10]  
[Anonymous], 2011, Off J Eur Union, VL275, P38, DOI DOI 10.2777/13162